Janux Therapeutics’ $56 Million Series A Financing

Martina Bellini
Tagged:

Wilson Sonsini Goodrich & Rosati advised Janux Therapeutics on the deal.Janux Therapeutics, a developer of safe, effective novel immunotherapies using its proprietary Tumor Activated T Cell…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now